Microbot Medical Inc. - Common Stock (NQ:MBOT)

2.538 +0.488 (+23.80%)

Streaming Delayed Price Updated: 11:27 AM EST, Feb 24, 2026 Add to My Watchlist

Price and Volume

Volume	4,312,145
Open	2.140
Bid (Size)	2.530 (2,200)
Ask (Size)	2.540 (4,500)
Prev. Close	2.050
Today's Range	2.130 - 2.570
52wk Range	1.250 - 4.670
Shares Outstanding	67,158,044
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

Today 10:30 EST

Via Chartmill

Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System

Today 8:30 EST

Early Post-Clearance Momentum Signals Accelerated Hospital Adoption of Advanced Robotics

From Microbot Medical Inc.

Via GlobeNewswire

Performance

YTD	+20.3%	+20.3%
1 Month	+32.2%	+32.2%
3 Month	+32.2%	+32.2%
6 Month	-39.0%	-39.0%
1 Year	+62.7%	+62.7%

More News

Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference

February 19, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference

February 12, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption

February 05, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones

January 12, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System

November 26, 2025

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

November 05, 2025

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

October 16, 2025

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System

October 14, 2025

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

October 07, 2025

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio

October 01, 2025

From Microbot Medical Inc.

Via GlobeNewswire

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

September 23, 2025

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds

September 16, 2025

From Microbot Medical Inc.

Via GlobeNewswire

Monday's session: gap up and gap down stocks ↗

September 15, 2025

Via Chartmill

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds

September 15, 2025

From Microbot Medical Inc.

Via GlobeNewswire

Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday ↗

September 11, 2025

Via Benzinga

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

September 09, 2025

From Microbot Medical Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 08, 2025

Via Benzinga

Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System

September 08, 2025

From Microbot Medical Inc.

Via GlobeNewswire

Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket ↗

September 08, 2025

Via Benzinga

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

August 20, 2025

From Microbot Medical Inc.

Via GlobeNewswire

DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors

August 08, 2025

From DIH Holding US, Inc.

Via GlobeNewswire

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

August 05, 2025

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

July 22, 2025

From Microbot Medical Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Microbot Medical Inc. - Common Stock publicly traded?

Yes, Microbot Medical Inc. - Common Stock is publicly traded.

What exchange does Microbot Medical Inc. - Common Stock trade on?

Microbot Medical Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Microbot Medical Inc. - Common Stock?

The ticker symbol for Microbot Medical Inc. - Common Stock is MBOT on the Nasdaq Stock Market

What is the current price of Microbot Medical Inc. - Common Stock?

The current price of Microbot Medical Inc. - Common Stock is 2.538

When was Microbot Medical Inc. - Common Stock last traded?

The last trade of Microbot Medical Inc. - Common Stock was at 02/24/26 11:27 AM ET

What is the market capitalization of Microbot Medical Inc. - Common Stock?

The market capitalization of Microbot Medical Inc. - Common Stock is 170.45M

How many shares of Microbot Medical Inc. - Common Stock are outstanding?

Microbot Medical Inc. - Common Stock has 170M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.